Opes Wealth Management LLC acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,413 shares of the financial services provider's stock, valued at approximately $375,000.
Other hedge funds also recently modified their holdings of the company. SeaCrest Wealth Management LLC raised its stake in shares of CME Group by 3.0% in the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after purchasing an additional 40 shares in the last quarter. New Age Alpha Advisors LLC raised its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. OneAscent Financial Services LLC raised its stake in CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after acquiring an additional 43 shares in the last quarter. Ballentine Partners LLC raised its stake in CME Group by 0.8% during the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after acquiring an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC raised its stake in CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after acquiring an additional 47 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the company. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Keefe, Bruyette & Woods raised their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Piper Sandler raised their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Morgan Stanley raised their price target on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $261.93.
View Our Latest Research Report on CME Group
Insider Activity at CME Group
In other news, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the transaction, the director directly owned 3,668 shares in the company, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 3,000 shares of the business's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the sale, the director owned 5,400 shares of the company's stock, valued at $1,471,824. This trade represents a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,400 shares of company stock worth $3,152,410 in the last three months. 0.30% of the stock is owned by company insiders.
CME Group Stock Up 0.9%
CME Group stock traded up $2.37 during midday trading on Friday, reaching $279.55. The stock had a trading volume of 1,834,736 shares, compared to its average volume of 2,117,443. The firm's fifty day simple moving average is $276.37 and its 200-day simple moving average is $261.89. CME Group Inc. has a 1-year low of $193.25 and a 1-year high of $290.79. The stock has a market capitalization of $100.74 billion, a P/E ratio of 27.06, a price-to-earnings-growth ratio of 4.85 and a beta of 0.44. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.56 EPS. As a group, analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.79%. CME Group's dividend payout ratio is currently 48.40%.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.